Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients - Petersen, R P; Campa, M J; Sperlazza, J; Conlon, D; Joshi, M B; Harpole, D H, jr.; Patz, E F, jr. (Cancer, 2006)